Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
AWH
|
James T Lafrance
Director |
BUY
Grant, award, or other acquisition
|
Direct | 72,937 Added 12.82% |
-
|
Mar 31
2022 |
AWH
|
Celeste Rachelle Fralick
Director |
BUY
Grant, award, or other acquisition
|
Direct | 99,671 Added 50.0% |
-
|
Mar 31
2022 |
AWH
|
Veronica Gh Jordan
Director |
BUY
Grant, award, or other acquisition
|
Direct | 73,656 Added 16.94% |
-
|
Mar 31
2022 |
GAIA
|
Paul C. Tarell Jr.
CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 50,000 Added 24.65% |
$246,000
$4.92 p/Share
|
Mar 31
2022 |
GAIA
|
Kiersten Medvedich
President |
BUY
Exercise of conversion of derivative security
|
Direct | 20,000 Added 47.17% |
$98,400
$4.92 p/Share
|
Mar 31
2022 |
GAIA
|
Jirka Rysavy |
BUY
Exercise of conversion of derivative security
|
Direct | 96,283 Added 1.61% |
-
|
Mar 31
2022 |
LJPC
|
Michael S Hearne
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 177 Added 1.93% |
$643
$3.63 p/Share
|
Mar 31
2022 |
LJPC
|
Larry G. Edwards
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 334 Added 2.78% |
$1,212
$3.63 p/Share
|
Mar 31
2022 |
SMLP
|
James David Johnston
Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 6,559 Reduced 18.42% |
$97,598
$14.88 p/Share
|
Mar 31
2022 |
SMLP
|
James David Johnston
Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 16,666 Added 31.89% |
-
|
Mar 31
2022 |
AGFS
|
Thomas Ermi
EVP,Secretary&General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 5,494 Reduced 9.16% |
$10,439
$1.9 p/Share
|
Mar 31
2022 |
AGFS
|
Clinton A. Lewis Jr.
CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 42,582 Reduced 12.08% |
$80,906
$1.9 p/Share
|
Mar 31
2022 |
AGFS
|
Graham G Miao
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 20,304 Reduced 12.07% |
$38,578
$1.9 p/Share
|
Mar 31
2022 |
TELA
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect | 5,000 Added 0.15% |
$57,700
$11.54 p/Share
|
Mar 31
2022 |
BCAB
|
Jay M Phd Short
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,888 Reduced 0.22% |
$14,440
$5.0 p/Share
|
Mar 31
2022 |
BCAB
|
Eric Sievers
Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 554 Reduced 0.62% |
$2,770
$5.0 p/Share
|
Mar 31
2022 |
BCAB
|
Scott Andrew Smith |
SELL
Payment of exercise price or tax liability
|
Direct | 1,791 Reduced 0.53% |
$8,955
$5.0 p/Share
|
Mar 31
2022 |
BCAB
|
Christian Vasquez |
SELL
Payment of exercise price or tax liability
|
Direct | 189 Reduced 0.75% |
$945
$5.0 p/Share
|
Mar 31
2022 |
BCAB
|
Richard A Waldron
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 970 Reduced 0.74% |
$4,850
$5.0 p/Share
|
Mar 31
2022 |
KRMD
|
Joseph M. Manko Jr.
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 5,221 Added 0.07% |
-
|
Mar 31
2022 |
KRMD
|
David W Anderson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,221 Added 8.16% |
$14,984
$2.87 p/Share
|
Mar 31
2022 |
KRMD
|
Donna French
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,221 Added 23.44% |
$14,984
$2.87 p/Share
|
Mar 31
2022 |
KRMD
|
Daniel S Goldberger
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,221 Added 4.16% |
$14,984
$2.87 p/Share
|
Mar 31
2022 |
KRMD
|
James M Beck
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,221 Added 7.17% |
$14,984
$2.87 p/Share
|
Mar 31
2022 |
KRMD
|
R John Fletcher
Director |
BUY
Grant, award, or other acquisition
|
Direct | 7,832 Added 6.65% |
$22,478
$2.87 p/Share
|
Mar 31
2022 |
KRMD
|
Kathy Frommer
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,221 Added 0.71% |
$14,984
$2.87 p/Share
|
Mar 31
2022 |
KRMD
|
Robert T Allen
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,221 Added 13.98% |
$14,984
$2.87 p/Share
|
Mar 31
2022 |
KRMD
|
Shahriar Matin
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5,221 Added 20.32% |
$14,984
$2.87 p/Share
|
Mar 31
2022 |
JAKK
|
John Joseph Mcgrath
Pres. of European Operations |
SELL
Payment of exercise price or tax liability
|
Direct | 2,783 Reduced 4.85% |
$40,326
$14.49 p/Share
|
Mar 31
2022 |
JAKK
|
Stephen G Berman
Chairman, CEO, and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct | 13,755 Reduced 15.21% |
$199,310
$14.49 p/Share
|
Mar 31
2022 |
FORA
|
Martin J Wygod |
BUY
Open market or private purchase
|
Indirect | 800 Added 0.03% |
$5,312
$6.64 p/Share
|
Mar 31
2022 |
AUD
|
David J Field
Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 75,659 Reduced 3.5% |
$231,517
$3.06 p/Share
|
Mar 31
2022 |
AUD
|
Elizabeth Bramowski
Principal Acctg Ofcr & Treasr |
SELL
Payment of exercise price or tax liability
|
Direct | 3,789 Reduced 4.51% |
$11,594
$3.06 p/Share
|
Mar 31
2022 |
AUD
|
John David Crowley
Chf Dgtl Off/Pres Podcast |
SELL
Payment of exercise price or tax liability
|
Direct | 17,382 Reduced 4.85% |
$53,189
$3.06 p/Share
|
Mar 31
2022 |
AUD
|
Susan Larkin
EVP & Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 25,728 Reduced 7.19% |
$78,728
$3.06 p/Share
|
Mar 31
2022 |
AUD
|
Richard J Schmaeling
CFO & EVP Strat. Initiatives |
SELL
Payment of exercise price or tax liability
|
Direct | 31,320 Reduced 5.11% |
$95,839
$3.06 p/Share
|
Mar 31
2022 |
AUD
|
Andrew P Iv Sutor
Exec. Vice Pres. & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct | 13,255 Reduced 3.82% |
$40,560
$3.06 p/Share
|
Mar 31
2022 |
RAIN
|
Robert Doebele
Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 2,000 Added 0.42% |
$7,900
$3.95 p/Share
|
Mar 31
2022 |
FCCO
|
Chimin J Chao
Director |
BUY
Grant, award, or other acquisition
|
Direct | 859 Added 1.07% |
$18,056
$21.02 p/Share
|
Mar 31
2022 |
FCCO
|
Alexander Snipe Jr
Director |
BUY
Grant, award, or other acquisition
|
Direct | 809 Added 1.94% |
$17,005
$21.02 p/Share
|
Mar 31
2022 |
FCCO
|
Edward J. Tarver |
BUY
Grant, award, or other acquisition
|
Direct | 143 Added 3.27% |
$3,006
$21.02 p/Share
|
Mar 31
2022 |
FCCO
|
Thomas Carlton Brown
Director |
BUY
Grant, award, or other acquisition
|
Direct | 642 Added 1.91% |
$13,495
$21.02 p/Share
|
Mar 31
2022 |
EPSN
|
Tracy B Stephens
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 7,500 Reduced 14.45% |
$48,075
$6.41 p/Share
|
Mar 31
2022 |
KULR
|
Terry Keith Cochran
President and COO |
SELL
Open market or private sale
|
Direct | 90,200 Reduced 24.69% |
$202,048
$2.24 p/Share
|
Mar 31
2022 |
VACC
|
Alex Hammacher
Director |
BUY
Open market or private purchase
|
Direct | 2,000 Added 40.0% |
$10,280
$5.14 p/Share
|
Mar 31
2022 |
MHLD
|
William Jarman
SVP & Chief Actuary |
SELL
Payment of exercise price or tax liability
|
Direct | 58,631 Reduced 40.2% |
-
|
Mar 31
2022 |
MHLD
|
William Jarman
SVP & Chief Actuary |
BUY
Grant, award, or other acquisition
|
Direct | 119,047 Added 44.94% |
-
|
Mar 31
2022 |
PRPL
|
Pano Anthos
Director |
BUY
Open market or private purchase
|
Direct | 3,278 Added 9.98% |
$19,701
$6.01 p/Share
|
Mar 31
2022 |
CPSS
|
Charles E Bradley Jr
CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 200,000 Added 5.8% |
$314,000
$1.57 p/Share
|
Mar 31
2022 |
SWKH
|
Laurie L. Dotter
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,709 Added 50.0% |
$28,848
$16.88 p/Share
|
Mar 31
2022 |